€CEBL
Este fundo tem por objetivo acompanhar o índice MSCI Emerging Markets Asia, que abrange empresas de grande e média capitalização dos mercados emergentes asiáticos.
Nome | Peso | Capitalização de mercado | Preço | Variação diária |
|---|---|---|---|---|
18,19% | N/A | N/A | N/A | |
8,52% | N/A | N/A | N/A | |
6,86% | N/A | N/A | N/A | |
4,27% | N/A | N/A | N/A | |
3,32% | N/A | N/A | N/A | |
2,23% | N/A | N/A | N/A | |
2,04% | N/A | N/A | N/A | |
1,08% | N/A | N/A | N/A | |
1,05% | N/A | N/A | N/A | |
0,97% | N/A | N/A | N/A | |
0,95% | N/A | N/A | N/A | |
0,83% | N/A | N/A | N/A | |
0,74% | N/A | N/A | N/A | |
0,68% | N/A | N/A | N/A | |
0,67% | N/A | N/A | N/A | |
0,63% | N/A | N/A | N/A | |
0,63% | N/A | N/A | N/A | |
0,59% | N/A | N/A | N/A | |
0,55% | N/A | N/A | N/A | |
0,53% | N/A | N/A | N/A | |
0,52% | N/A | N/A | N/A | |
0,5% | N/A | N/A | N/A | |
0,48% | N/A | N/A | N/A | |
0,47% | N/A | N/A | N/A | |
0,45% | N/A | N/A | N/A | |
0,41% | N/A | N/A | N/A | |
0,41% | N/A | N/A | N/A | |
PDD $PDDOutroBens essenciais de consumo | 0,4% | - | ||
0,4% | N/A | N/A | N/A | |
0,4% | N/A | N/A | N/A | |
0,37% | N/A | N/A | N/A | |
0,36% | N/A | N/A | N/A | |
0,36% | N/A | N/A | N/A | |
0,35% | N/A | N/A | N/A | |
0,34% | N/A | N/A | N/A | |
0,34% | N/A | N/A | N/A | |
0,33% | N/A | N/A | N/A | |
Infosys $INFYOutroServiços | 0,33% | - | ||
0,31% | N/A | N/A | N/A | |
0,3% | N/A | N/A | N/A | |
0,3% | N/A | N/A | N/A | |
0,29% | N/A | N/A | N/A | |
0,29% | N/A | N/A | N/A | |
0,28% | N/A | N/A | N/A | |
0,28% | N/A | N/A | N/A | |
0,28% | N/A | N/A | N/A | |
0,28% | N/A | N/A | N/A | |
0,28% | N/A | N/A | N/A | |
0,27% | N/A | N/A | N/A | |
0,27% | N/A | N/A | N/A | |
0,26% | N/A | N/A | N/A | |
0,26% | N/A | N/A | N/A | |
0,26% | N/A | N/A | N/A | |
0,25% | N/A | N/A | N/A | |
0,25% | N/A | N/A | N/A | |
0,24% | N/A | N/A | N/A | |
0,24% | N/A | N/A | N/A | |
0,24% | N/A | N/A | N/A | |
0,23% | N/A | N/A | N/A | |
0,23% | N/A | N/A | N/A | |
0,23% | N/A | N/A | N/A | |
0,22% | N/A | N/A | N/A | |
0,21% | N/A | N/A | N/A | |
0,21% | N/A | N/A | N/A | |
0,21% | N/A | N/A | N/A | |
0,21% | N/A | N/A | N/A | |
0,21% | N/A | N/A | N/A | |
BeOne Medicines AG $ONCOutroSaúde | 0,21% | - | ||
0,21% | N/A | N/A | N/A | |
0,21% | N/A | N/A | N/A | |
0,2% | N/A | N/A | N/A | |
0,19% | N/A | N/A | N/A | |
0,19% | N/A | N/A | N/A | |
0,19% | N/A | N/A | N/A | |
0,19% | N/A | N/A | N/A | |
0,19% | N/A | N/A | N/A | |
0,19% | N/A | N/A | N/A | |
0,19% | N/A | N/A | N/A | |
0,19% | N/A | N/A | N/A | |
0,18% | N/A | N/A | N/A | |
0,18% | N/A | N/A | N/A | |
0,17% | N/A | N/A | N/A | |
0,17% | N/A | N/A | N/A | |
0,17% | N/A | N/A | N/A | |
0,17% | N/A | N/A | N/A | |
0,17% | N/A | N/A | N/A | |
0,17% | N/A | N/A | N/A | |
0,17% | N/A | N/A | N/A | |
0,17% | N/A | N/A | N/A | |
0,17% | N/A | N/A | N/A | |
0,17% | N/A | N/A | N/A | |
0,17% | N/A | N/A | N/A | |
0,17% | N/A | N/A | N/A | |
0,17% | N/A | N/A | N/A | |
0,17% | N/A | N/A | N/A | |
0,16% | N/A | N/A | N/A | |
0,16% | N/A | N/A | N/A | |
0,16% | N/A | N/A | N/A | |
0,16% | N/A | N/A | N/A | |
0,15% | N/A | N/A | N/A | |
0,15% | N/A | N/A | N/A | |
0,15% | N/A | N/A | N/A | |
0,15% | N/A | N/A | N/A | |
0,15% | N/A | N/A | N/A | |
0,15% | N/A | N/A | N/A | |
0,15% | N/A | N/A | N/A | |
0,15% | N/A | N/A | N/A | |
0,15% | N/A | N/A | N/A | |
0,15% | N/A | N/A | N/A | |
0,14% | N/A | N/A | N/A | |
0,14% | N/A | N/A | N/A | |
0,14% | N/A | N/A | N/A | |
0,14% | N/A | N/A | N/A | |
0,14% | N/A | N/A | N/A | |
0,14% | N/A | N/A | N/A | |
0,13% | N/A | N/A | N/A | |
0,13% | N/A | N/A | N/A | |
0,13% | N/A | N/A | N/A | |
0,13% | N/A | N/A | N/A | |
0,13% | N/A | N/A | N/A | |
0,12% | N/A | N/A | N/A | |
0,12% | N/A | N/A | N/A | |
0,12% | N/A | N/A | N/A | |
0,12% | N/A | N/A | N/A | |
0,12% | N/A | N/A | N/A | |
0,12% | N/A | N/A | N/A | |
0,12% | N/A | N/A | N/A | |
0,12% | N/A | N/A | N/A | |
0,12% | N/A | N/A | N/A | |
0,12% | N/A | N/A | N/A | |
0,12% | N/A | N/A | N/A | |
0,12% | N/A | N/A | N/A | |
0,11% | N/A | N/A | N/A | |
0,11% | N/A | N/A | N/A | |
0,11% | N/A | N/A | N/A | |
0,11% | N/A | N/A | N/A | |
0,11% | N/A | N/A | N/A | |
0,11% | N/A | N/A | N/A | |
0,11% | N/A | N/A | N/A | |
0,11% | N/A | N/A | N/A | |
0,11% | N/A | N/A | N/A | |
0,11% | N/A | N/A | N/A | |
0,11% | N/A | N/A | N/A | |
0,11% | N/A | N/A | N/A | |
0,11% | N/A | N/A | N/A | |
0,11% | N/A | N/A | N/A | |
0,11% | N/A | N/A | N/A | |
0,1% | N/A | N/A | N/A | |
0,1% | N/A | N/A | N/A | |
0,1% | N/A | N/A | N/A | |
0,1% | N/A | N/A | N/A | |
0,1% | N/A | N/A | N/A | |
0,1% | N/A | N/A | N/A | |
0,1% | N/A | N/A | N/A | |
0,1% | N/A | N/A | N/A | |
0,1% | N/A | N/A | N/A | |
0,1% | N/A | N/A | N/A | |
0,1% | N/A | N/A | N/A | |
0,1% | N/A | N/A | N/A | |
0,1% | N/A | N/A | N/A | |
0,1% | N/A | N/A | N/A | |
0,09% | N/A | N/A | N/A | |
0,09% | N/A | N/A | N/A | |
0,09% | N/A | N/A | N/A | |
0,09% | N/A | N/A | N/A | |
0,09% | N/A | N/A | N/A | |
0,09% | N/A | N/A | N/A | |
0,09% | N/A | N/A | N/A | |
0,09% | N/A | N/A | N/A | |
0,09% | N/A | N/A | N/A | |
0,09% | N/A | N/A | N/A | |
0,09% | N/A | N/A | N/A | |
0,09% | N/A | N/A | N/A | |
0,09% | N/A | N/A | N/A | |
0,09% | N/A | N/A | N/A | |
0,08% | N/A | N/A | N/A | |
0,08% | N/A | N/A | N/A | |
0,08% | N/A | N/A | N/A | |
0,08% | N/A | N/A | N/A | |
0,08% | N/A | N/A | N/A | |
0,08% | N/A | N/A | N/A | |
0,08% | N/A | N/A | N/A | |
0,08% | N/A | N/A | N/A | |
0,08% | N/A | N/A | N/A | |
0,08% | N/A | N/A | N/A | |
0,08% | N/A | N/A | N/A | |
0,08% | N/A | N/A | N/A | |
0,08% | N/A | N/A | N/A | |
0,08% | N/A | N/A | N/A | |
H World Group $HTHTOutroConsumo cíclico | 0,08% | - | ||
0,08% | N/A | N/A | N/A | |
0,08% | N/A | N/A | N/A | |
0,08% | N/A | N/A | N/A | |
0,08% | N/A | N/A | N/A | |
0,08% | N/A | N/A | N/A | |
0,08% | N/A | N/A | N/A | |
0,08% | N/A | N/A | N/A | |
0,08% | N/A | N/A | N/A | |
0,08% | N/A | N/A | N/A | |
0,07% | N/A | N/A | N/A |